January Blog
US$ 22.22
generic glp-1 agonist FDA approves first liraglutide once-daily injection Letter: Association Between Incretin Mimetics
Description
Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats
While it's been explored in research settings for weight management applications, BAM15 has never been approved for human use
Overall, tirzepatides dual agonism of GLP1 and GIP receptors appears to provide encouraging cardiovascular benefits beyond glycemic control, offering a potential new therapeutic option for treating cardiovascular diseases and heart failure
Borlaug B
Microvascular benefits of new antidiabetic agents: A systematic review and network meta-analysis of kidney outcomes
